Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial - Coleman, R L; Oza, A M; Lorusso, D (Lancet, 2017)